Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Cardio ThinkLab: We keep our finger on the pulse

## Sitemaps
[XML Sitemap](https://cardiothinklab.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [Taking Diabetes to Heart: The Value of NT-proBNP Testing for CVD Risk Assessment in Diabetes](https://cardiothinklab.com/taking-diabetes-to-heart-the-value-of-nt-probnp-testing-for-cvd-risk-assessment-in-diabetes/): Join our expert-led educational webinar, “Taking Diabetes to Heart: The Value of NT-proBNP Testing for CVD Risk Assessment in Diabetes,” to explore the evolving role of NT-proBNP as a powerful tool for early CVD risk assessment. Our expert speakers will delve into the latest clinical guidelines and real-world evidence from the PISCES study involving multi-ethnic Asian populations, reviewing why traditional risk markers often fall short and how NT-proBNP testing is transforming early CVD risk stratification.
- [NT-proBNP for Cardiovascular Risk Stratification in T2DM: From Evidence to Clinical Practice](https://cardiothinklab.com/nt-probnp-for-cardiovascular-risk-stratification-in-t2dm/): Discover how NT-proBNP aids in cardiovascular risk stratification for T2DM patients and its implications for clinical practice.
- [Perioperative Myocardial Injury (PMI): How to Build and Implement a Successful Multidisciplinary Team Protocol](https://cardiothinklab.com/perioperative-myocardial-injury-multidisciplinary-team-protocol/): Addressing Perioperative Myocardial Injury with a Multidisciplinary Team Protocol - experiences from Ramathibodi Hospital, Bangkok, Thailand.
- [Beyond HbA1C: Overcoming Challenges in Insulin-Treated Type 2 Diabetes](https://cardiothinklab.com/beyond-hba1c-overcoming-challenges-in-insulin-treated-type-2-diabetes/): Dr Daphne Gardner talks about overcoming challenges in insulin-treated type 2 diabetes with the help of continuous glucose monitoring and AI-assisted technology.
- [APSC Consensus Statement on the Management of Worsening Heart Failure](https://cardiothinklab.com/apsc-consensus-statement-management-worsening-heart-failure/): Dr David Sim shares key recommendations for the management of worsening Heart Failure from the APSC Consensus Statement.
- [Navigating Cardiotoxicity: A Practical Guide to Cardiac Biomarkers during Chemotherapy](https://cardiothinklab.com/navigating-cardiotoxicity-cardiac-biomarkers-chemotherapy/): Prof Hyukjin Park discusses cardiac biomarkers during chemotherapy and the critical issue of cardiotoxicity.
- [Continuous Glucose Monitoring with AI-enabled Predictive Algorithms for Diabetes Care: Expert Views from Hong Kong](https://cardiothinklab.com/continuous-glucose-monitoring-predictive-algorithms-diabetes-hong-kong/): Dr Elaine Chow discusses advances in continuous glucose monitoring and AI-enabled predictive algorithms in diabetes care.
- [Optimising Perioperative Outcomes: A Practical Guide to Cardiac Biomarkers in Noncardiac Surgery](https://cardiothinklab.com/cn-consensus-pmi-non-cardiac/): The 2025 Expert Consensus on cardiac biomarkers strongly recommends using hs-cTn, often combined with BNP/NT-proBNP, for both preoperative risk assessment and postoperative surveillance (daily for 48-72 hours) in high-risk patients undergoing noncardiac surgery.
- [NT-proBNP as an Effective Screening Tool for CVD in People with Diabetes](https://cardiothinklab.com/nt-probnp-as-an-effective-screening-tool-for-cvd-in-people-with-diabetes/): Prof Rodica Busui sheds light on the use of NT-proBNP for cardiovascular risk assessment in people with diabetes.
- [MASH and Hepatic Fibrosis: Intersecting Metabolic Pathways](https://cardiothinklab.com/mash-and-hepatic-fibrosis-intersecting-metabolic-pathways/): Explore intersecting metabolic pathways between MASH, Hepatic Fibrosis and cardiovascular diseases.
- [How to Manage PMI? – Practical Implementation in Ramathibodi Hospital](https://cardiothinklab.com/how-to-manage-pmi-practical-implementation-in-ramathibodi-hospital/): Experiences from Ramathibodi Hospital in managing perioperative myocardial injuries.
- [Lp(a) Screening at Least Once a Lifetime! Unwrapping the What, Why and How’s of Lipoprotein(a)](https://cardiothinklab.com/lpa-screening-at-least-once-a-lifetime-unwrapping-the-what-why-and-hows-of-lipoproteina/): Uncover the benefits of screening for lipoprotein a, i.e., lp(a) at least once a lifetime.
- [NT-proBNP as a predictor of Cardio-renal Complications in PwD](https://cardiothinklab.com/nt-probnp-as-a-predictor-of-cardio-renal-complications-in-pwd/): Discover how NT-proBNP can facilitate management of cardio-renal complications in people with diabetes.
- [Safety of Rx Optimisation Post AHF Hospitalization](https://cardiothinklab.com/safety-of-rx-optimisation-post-ahf-hospitalization/): Q8. What is the overarching goal of post-AHF optimization? To rapidly transition patients from unstable AHF hospitalization to stabilized, disease-modified chronic HF with minimized residual congestion and reduced early events.  
- [Use of Rapid Algo for Suspected AMI – Faster Triage of ED Patients](https://cardiothinklab.com/use-of-rapid-algo-for-suspected-ami-faster-triage-of-ed-patients/): Discover how the use of rapid algo enhances the triage process for suspected AMI in emergency department patients.
- [Navigating Cardiotoxicity – Value of Cardiac Biomarkers](https://cardiothinklab.com/navigating-cardiotoxicity-value-of-cardiac-biomarkers/): This section presents a concise, high-yield summary of the video's core content, designed as a quick reference for Healthcare Professionals (HCPs).
- [DROP Asian ACS – Validation of the ESC 0/1-Hour Algorithm for Chest Pain Triage in Asian EDs](https://cardiothinklab.com/drop-asian-acs-study-results-and-practical-approach/): Discover how the ESC 0/1-hour algorithm effectively triages chest pain in Asian emergency departments in the DROP-Asian study.
- [The Importance of Early Diagnosis and Management of Acute Heart Failure (AHF)](https://cardiothinklab.com/the-importance-of-early-diagnosis-and-management-of-ahf/): NT-proBNP provides an objective and reproducible biomarker that improves diagnostic accuracy when HF is suspected.
- [Integrative Approaches to Managing Diabetes and Cardiovascular Disease](https://cardiothinklab.com/integrative-approaches-to-managing-diabetes-and-cardiovascular-disease/): Discover how integrating digital metabolic data with AI tools allows clinicians to move beyond HbA1c snapshots, enabling more precise, phenotype-based cardiovascular care.
- [Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights](https://cardiothinklab.com/optimising-gdmt-post-ahf-discharge-apac-apsc-consensus-highlights/): This section presents a concise, high-yield summary of the video's core content, designed as a quick reference for Healthcare Professionals (HCPs).
- [Initiation of GDMT Therapy in Patients Discharged Post AHF – What are the Guardrails?](https://cardiothinklab.com/initiation-of-gdmt-therapy-in-patients-discharged-post-ahf-what-are-the-guardrails/): This section presents a concise, high-yield summary of the video's core content, designed as a quick reference for Healthcare Professionals (HCPs).
- [Enhancing Diabetes and Cardiovascular Management with Continuous Glucose Monitoring (CGM)](https://cardiothinklab.com/enhancing-diabetes-and-cardiovascular-management-with-continuous-glucose-monitoring/): Discover how CGM enhances diabetes and cardiovascular management for better patient outcomes.
- [New Frontiers for Risk Stratification Assays for Acute Coronary Syndrome – The Gen6 Assay for hs cTnT](https://cardiothinklab.com/new-frontiers-risk-stratification-gen-6-hs-ctnt/): This section presents a concise, high-yield summary of the video's core content, designed as a quick reference for Healthcare Professionals (HCPs).
- [NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan](https://cardiothinklab.com/nt-probnp-for-rapid-optimisation-of-gdmt-in-ahf-patients-in-japan/): This section presents a concise, high-yield summary of the video's core content, designed as a quick reference for Healthcare Professionals (HCPs).
- [ACC 2025 Spotlight: DROP-Asian ACS Interim Analysis Highlights Regional Gains in NSTEMI Care](https://cardiothinklab.com/drop-asian-acs-nstemi/): Following the recent presentation of the late-breaking DROP-Asian ACS trial at the ACC conference 2025, Dr. Kenji Inoue, a Cardiologist of Juntendo University Nerima Hospital, Tokyo, discussed the trial's critical role in addressing disparities in cardiac care across the Asia Pacific (APAC) region related to the management of patients with Non-ST-Elevation Myocardial Infarction (NSTEMI). Dr. Inoue highlighted the absence of a unified approach, stating, "In the Asian Pacific area...we do not have an integrated guideline, which can cover all Asian countries"
- [Empowering the Everyday: AI-enabled CGM Is the Next Leap in Diabetes Care](https://cardiothinklab.com/empowering-the-everyday-ai-enabled-cgm-is-the-next-leap-in-diabetes-care/): Live from the APAC HCP Roundtable Meeting: find out more about AI-enabled CGM and how it overcome the limitations of current CGMs by offering predictive alerts and forecasts, ultimately improving glycemic control and reducing patient burden.
- [Lipoprotein(a) in clinical practice](https://cardiothinklab.com/lipoprotein-a-in-clinical-practice/): Lipoprotein(a), or the short form Lp(a), is an inherited type of lipoprotein made in our liver.⁴ Lp(a) looks like LDL lipid particle, but with the addition of an apo(a) chain, hence its name Lp(a).⁵ 
- [Diabetes and Hajj: Doctor’s Awareness Program](https://cardiothinklab.com/diabetes-and-hajj-doctors-awareness-program/)
- [STRONG-HF Japan Study](https://cardiothinklab.com/strong-hf-japan/): The STRONG-HF Japan study adapted a rapid GDMT up-titration protocol for acute HF patients. It emphasized in-hospital monitoring and comprehensive GDMT. Learn more in this interview with Dr Ishihara Shiro.
- [Diabetes and Ramadan: Public Awareness Program](https://cardiothinklab.com/diabetes-and-ramadan-public-awareness-program/)
- [Innovative Strategies to Optimise Heart Failure GDMT at Prince Wales Hospital’s Heart Failure Clinic](https://cardiothinklab.com/innovative-strategies-to-optimise-heart-failure-gdmt-at-prince-wales-hospitals-heart-failure-clinic/): I think the main challenges right now in Hong Kong is that kind of the population (HF population) are getting sicker and sicker. And then we have a lot of patients come in with HFrEF as well, and their outcome is really bad. The HF hospitalisation readmission rate could be up to around 20% in 3 months time, the mortality is actually very high.  So I think that we need something better, such as the ambulatory HF clinics or ambulatory centre to follow-up these patients more closely and to introduce and uptitrate the GDMT in order to help these patients out. 
- [STRONG-HF Recommended in Updated China National Heart Failure Guideline 2023](https://cardiothinklab.com/strong-hf-recommended-in-updated-china-national-heart-failure-guideline-2023/): I’m Yuhui Zhang from China Fuwai Hospital, also named as the National Centre of Cardiovascular Diseases (NCCD), and I am Director of the Heart Failure Centre of Fuwai Hospital. I majored in heart failure (HF), cardiomyopathy, and cardio-oncology. 
- [Rapid Titration (RaT) Pathway For Optimising Heart Failure GDMT with comprising several hospitals in Northland](https://cardiothinklab.com/optimising-heart-failure-gdmt-with-the-rapid-titration-rat-pathway-comprising-several-hospitals-in-northland/): We know from evidence that to get patients on guideline-directed medical therapy (GDMT) for HF, it's really important to start early and to up-titrate early. The STRONG-HF trial, for example, highlights that it's feasible, it's safe, and it gets through that patient's high risk period where they're more likely to not take their medications and have subsequent events and readmission. We've got a high readmission rate, which of course results in morbidity as well as mortality, with about 1 in 5 of our patients readmitted in 90 days. The other thing is that if we get the patients started onto a program of rapid titration, they're more likely to engage with the service and adhere to their medication in the long term. One of the challenges that we have in Northland is that the primary care follow-up is poor. There's a shortage of GPs. The population is largely rural, deprived, and so access to get to those GPs can be challenging. Health literacy is often poor and we've got a high burden of disease, often quite complex disease, in our Māori patients and the young patients. And so if we can get these patients engaged early in a rapid titration, it's a win-win for the patient, both short term and long term.
- [Ramadan & Diabetes](https://cardiothinklab.com/ramadan-diabetes/)
- [International Speaker Program (ISP) From Diabetes to Wellbeing: A Global Dialogue on Holistic Health](https://cardiothinklab.com/international-speaker-program-isp-from-diabetes-to-wellbeing-a-global-dialogue-on-holistic-health/): Download the summary report
- [Reducing Mortality and Readmission with HF Multidisciplinary Model of Care](https://cardiothinklab.com/reducing-mortality-and-readmission-with-hf-multidisciplinary-model-of-care/): I knew that the model that we came up with needed to be a model that could do, that could rise to the challenge of big numbers while catering to the complexity of the disease process and individualize to different patients. The Australian, American and European guidelines recommend multidisciplinary care with the highest level of evidence , but unfortunately, the reality of it is that the uptake of this model has never been all that great, and this is purely related to logistics, staffing as well as the complexity of managing a team in this way. We felt that, you know, the multidisciplinary model of care was a model of care that could cater to the complexity of the disease and also overcome the barriers that we would need to overcome to optimize treatment.
- [Implementing 0/1-Hour Algorithm using High-Sensitivity Cardiac Troponin in the Emergency Department](https://cardiothinklab.com/implementing-0-1-hour-algorithm-using-high-sensitivity-cardiac-troponin-in-the-emergency-department/): Is your emergency department (ED) experiencing overcrowding due to the long turnaround time for investigation and decision-making? Is your ED experiencing difficulty triaging patients presenting with chest pain due to varying types of clinical presentation and risk factors?
- [Culturally Sensitive Diabetes Care](https://cardiothinklab.com/culturally-sensitive-diabetes-care/): Diabetes is largely a self-managed disease.1 Education tailored to the individual patient is therefore vital to ensure optimal patient health and wellbeing. In our current multicultural society, the influence of different cultures and backgrounds on nutrition must be considered when individualising diabetes care and management. Professor Winnie Chee from International Medical University, Malaysia, presented on diabetes management in Malaysia’s multicultural landscape.
- [What Causes Falsely High & Low HbA1c Reading?](https://cardiothinklab.com/hba1c-discrepancies-how-can-ambulatory-glucose-pro%ef%ac%81le-agp-help/): What is HbA1c? It is a key marker used for diagnostic and monitoring purposes in the management of diabetes.1 However, HbA1c has its limitations, including discrepancies with self monitoring of blood glucose (SMBG) readings. Associate Professor Roy Rasalam from University of Melbourne, Australia, gave a presentation on HbA1c discordance and how this can be managed in clinical practice.
- [Menopause and Diabetes](https://cardiothinklab.com/menopause-and-diabetes/): It is estimated that over one billion females will be in menopause transition or postmenopause by 2030.1 About 8 in 10 females will experience menopause symptoms which can persist and change throughout menopause.2 Menopause is often not considered in the context of diabetes. However, Ms Wendy Bryant, Lifestyle Medicine Practitioner from Mater Hospital, North Sydney, discussed the bidirectional relationship between diabetes and menopause, and how both can be optimally managed.
- [World Anaesthesia Day: Dawn of a New Era in the Management of Perioperative Myocardial Infarction (PMI)](https://cardiothinklab.com/world-anaesthesia-day-dawn-of-a-new-era-in-the-management-of-perioperative-myocardial-infarction-pmi/): Please view the recording in Vietnamese or Japanese here
- [EMPORIUM – Full Throttle Against HF: From Detection to Protection](https://cardiothinklab.com/emporium-full-throttle-against-hf-from-detection-to-protection/)
- [Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day](https://cardiothinklab.com/every-heartbeat-counts-cvd-in-apac/): In order to tackle the rising burden of CVD in APAC countries, the APAC CVD Alliance report suggests that every country needs a nationally cohesive CVD strategy. Strategies should incorporate the entire patient journey, types of CVD and related chronic diseases, and tailored to the needs of the national CVD ecosystem. 
- [The effectiveness of telemonitoring and integrated personalised diabetes management in people with insulin-treated type 2 diabetes mellitus](https://cardiothinklab.com/the-effectiveness-of-telemonitoring-and-integrated-personalised-diabetes-management-in-people-with-insulin-treated-type-2-diabetes-mellitus/): Access the full publication
- [Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP](https://cardiothinklab.com/screening-for-occult-heart-failure-hf-in-type-2-diabetes-mellitus-t2dm-using-nt-probnp/): Hello I am Dr. Ameya Joshi. I am consultant in charge of endocrinology at Bhaktivedanta Hospital and Research Institute as well as Endocrine and Diabetes Clinic Mumbai.
- [Value of biomarker in HFpEF Diagnosis](https://cardiothinklab.com/value-of-biomarker-in-hfpef-diagnosis/): Thank you so much. And you know, until last year, we really didn't have definitive therapies for heart failure with preserved ejection fraction. So I think as a community, we're only now building programs to really identify heart failure with preserved ejection fraction at an earlier time point. This population too is older, has multiple comorbidities, has frailty, and so many of the symptoms that may be truly related to heart failure may be misattributed to other comorbidities,and may be put off as perhaps just a symptom of aging. I think that re-education process is one that's gonna be so critical to move the diagnosis to an earlier time point in the trajectory of HFpEF.
- [Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)](https://cardiothinklab.com/chinese-expert-consensus-on-the-risk-assessment-and-management-of-panvascular-disease-inpatients-with-type-2-diabetes-mellitus-2022-edition/): In 2022, the updated China Expert Consensus on Risk Assessment and Management of Panvascular Diseases in Patients with Type 2 Diabetes (hereinafter referred to as the consensus) has been officially released. This consensus was simultaneously published in 4 major journals: Chinese Journal of Diabetes, Chinese Journal of Health Management, Chinese Circulation Journal, and Cardiology Plus.
- [Communicating the value of CVD screening in T2DM to patients](https://cardiothinklab.com/communicating-the-value-of-cvd-screening-in-t2dm-to-patients/)
- [Lipoprotein(a): The science behind the Risk Factor](https://cardiothinklab.com/lipoproteina-the-science-behind-the-risk-factor/)

## Pages
- [About Us](https://cardiothinklab.com/about-us/): Cardio Thinklab is a scientific educational portal for healthcare professionals passionate about cardiovascular disease management.
- [Home](https://cardiothinklab.com/)

## FAQs

## Authors
- [Assoc. Prof. Yuya Matsue](https://cardiothinklab.com/experts/assoc-prof-yuya-matsue/)
- [Dr Lisa Sangkum](https://cardiothinklab.com/experts/dr-lisa-sangkum/)
- [Dr Daphne Gardner](https://cardiothinklab.com/experts/dr-daphne-gardner/)
- [Dr Chung-Lieh Hung](https://cardiothinklab.com/experts/dr-chung-lieh-hung/)
- [Prof Lori Daniels](https://cardiothinklab.com/experts/prof-lori-daniels/)
- [Prof Elaine Chow](https://cardiothinklab.com/experts/prof-elaine-chow/)
- [Dr Om J Lakhani](https://cardiothinklab.com/experts/dr-om-j-lakhani/)
- [Dr Raja Ezman Faridz](https://cardiothinklab.com/experts/dr-raja-ezman-faridz/)
- [Prof Hyukjin Park](https://cardiothinklab.com/experts/prof-hyukjin-park/)
- [Prof Rob Doughty](https://cardiothinklab.com/experts/prof-rob-doughty/)
- [Dr Vu Hoang Vu](https://cardiothinklab.com/experts/dr-vu-hoang-vu/)
- [Dr Anand V. Kulkarni](https://cardiothinklab.com/experts/dr-anand-v-kulkarni/)
- [Prof Rodica Busui](https://cardiothinklab.com/experts/prof-rodica-busui/)
- [Dr Loh Wann Jia](https://cardiothinklab.com/experts/dr-loh-wann-jia/)
- [Dr Shiro Ishihara](https://cardiothinklab.com/experts/dr-shiro-ishihara/)
- [Dr Raewyn Fisher](https://cardiothinklab.com/experts/dr-raewyn-fisher/)
- [Professor Dr Rohana Abdul Ghani](https://cardiothinklab.com/experts/professor-dr-rohana-abdul-ghani/)
- [Professor Dr Dalal Alromaihi](https://cardiothinklab.com/experts/dr-dalal-alromaihi/)
- [Dr Shehla Sheikh](https://cardiothinklab.com/experts/dr-shehla-sheikh/)
- [Professor Dr Yakoob Ahmedani](https://cardiothinklab.com/experts/dr-yakoob-ahmedani/)
- [Dr Bishwajit Bhowmik](https://cardiothinklab.com/experts/dr-bishwajit-bhowmik/)
- [Ms Anita Sabidi](https://cardiothinklab.com/experts/anita-sabidi/)
- [Dr Abdul Basit](https://cardiothinklab.com/experts/dr-abdul-basit/)
- [Dr Uday Phadke](https://cardiothinklab.com/experts/dr-uday-phadke/)
- [Dr Gary Gan](https://cardiothinklab.com/experts/dr-gary-gan/)
- [Ms Wendy Bryant](https://cardiothinklab.com/experts/ms-wendy-bryant/)
- [A/Prof Roy Rasalam](https://cardiothinklab.com/experts/a-prof-roy-rasalam/)
- [Prof Winnie Chee](https://cardiothinklab.com/experts/prof-winnie-chee/)
- [Dr Joshua Chung](https://cardiothinklab.com/experts/dr-joshua-chung/)
- [Dato’ Dr Azmee Mohd Ghazi](https://cardiothinklab.com/experts/dato-dr-azmee-mohd-ghazi/)
- [Dr Ameya Joshi](https://cardiothinklab.com/experts/dr-ameya-joshi/)
- [Dr Muthiah Vaduganathan](https://cardiothinklab.com/experts/dr-muthiah-vaduganathan/)
- [Dr Sanjay Kalra](https://cardiothinklab.com/experts/dr-sanjay-kalra/)
- [Asst Prof Jasper Tromp](https://cardiothinklab.com/experts/asst-prof-jasper-tromp/)
- [Assoc Prof Karam Kostner](https://cardiothinklab.com/experts/assoc-prof-karam-kostner/)
- [Assoc Prof David Sullivan](https://cardiothinklab.com/experts/assoc-prof-david-sullivan/)
- [Prof Stephen Nicholls](https://cardiothinklab.com/experts/prof-stephen-nicholls/)
- [Prof Emily Lau](https://cardiothinklab.com/experts/prof-emily-lau/)
- [Dr Michael McGee](https://cardiothinklab.com/experts/dr-michael-mcgee/)
- [Prof Andrew JS Coats](https://cardiothinklab.com/experts/prof-andrew-js-coats/)
- [Dr Farina Mohd Salleh](https://cardiothinklab.com/experts/dr-farina-mohd-salleh/)
- [Dr Aekarach Ariyachaipanich](https://cardiothinklab.com/experts/dr-aekarach-ariyachaipanich/)
- [Dr Christian Puelacher](https://cardiothinklab.com/experts/dr-christian-puelacher/)
- [Dr Danielle Gualandro](https://cardiothinklab.com/experts/danielle-gualandro/)
- [Prof Jiang Hongli](https://cardiothinklab.com/experts/prof-jiang-hongli/)
- [Prof John Amerena](https://cardiothinklab.com/experts/prof-john-amerena/)
- [Dr Prin Vathesatogkit](https://cardiothinklab.com/experts/dr-prin-vathesatogkit/)
- [Prof Upendra Kaul](https://cardiothinklab.com/experts/prof-upendra-kaul/)
- [Prof Sazzli Kasim](https://cardiothinklab.com/experts/prof-sazzli-kasim/)
- [Prof Alexandre Mebazaa](https://cardiothinklab.com/experts/prof-alexandre-mebazaa/)